Contact Lens Spectrum

References

May 2019

Document #282

(p. 12) Refractive Focus – An Ode to My Retinoscope
By Roxanna T. Potter, OD

  1. Al-Mahrouqi H, Oraba SB, Al-Habsi S, et al. Retinoscopy as a Screening Tool for Keratoconus. Cornea. 2019 Apr;38:442-445.
  2. Benjamin WJJ. The “explicability” of cylinder axis and power in refractions over toric soft lenses. Cont Lens Anterior Eye. 1998 May-June;25:89-92.
  3. Schulle KL, Berntsen DA, Sinnott LT, et al; Bifocal Lenses in Nearsighted Kids Study Group. Visual Acuity and Over-refraction in Myopic Children Fitted with Soft Multifocal Contact Lenses. Optom Vis Sci. 2018;95:292-298.

(p. 19) Contact Lens Care & Compliance – Compliance with Cosmetic Contact Lenses
By Melissa Barnett, OD

  1. Abdelkader A. Cosmetic soft contact lens associated ulcerative keratitis in southern Saudi Arabia. Middle East Afr J Ophthalmol. 2014 Jul-Sep;21:232-235.
  2. Singh S, Satani D, Patel A, Vhankade R. Colored cosmetic contact lenses: an unsafe trend in the younger generation. Cornea. 2012 Jul;31:777-779.
  3. Gaiser H, Ho C, Janier N, Wee A, Johnson C, Watanabe R. Practitioner Perceptions of Patients Wearing Decorative Contact Lenses Purchased Through Unauthorized Sellers, Eye Contact Lens. 2017 Mar;43:135-139.
  4. Berenson AB, Hirth JM, Chang M, Merkley KH. Knowledge and Use of Cosmetic Contact Lenses Among Reproductive-Age Women. J Womens Health (Larchmt). 2019 Mar:28:403-409. [Epub ahead of print]
  5. Steinemann TL, Fletcher M, Bonny AE, et al. Over-the-counter decorative contact lenses: Cosmetic or Medical Devices? A Case Series. Eye Contact Lens. 2005 Sep;31:194-200.
  6. Zimmerman AB, Richdale K, Mitchell GL, et al. Water Exposure is a Common Risk Behavior Among Soft and Gas-Permeable Contact Lens Wearers. Cornea. 2017 Aug;36:995-1001.
  7. Centers for Disease Control and Prevention. Protech Your Eyes: You only have one pair of eyes, so take care of them! Healthy Habits = Healthy Eyes. Available at https://www.cdc.gov/contactlenses/protect-your-eyes.html . Accessed April 23, 2019.

(p. 41) Orthokeratology Today – What Does Ortho-k Do for Patients?
By Michael J. Lipson, OD

  1. Lipson MJ, Sugar A, Musch DC. Overnight corneal reshaping versus soft disposable contact lenses: vision-related quality-of-life differences from a randomized clinical trial. Optom Vis Sci. 2005 Oct;82:886-891.
  2. Hiraoka T, Okamoto C, Ishii Y, et al. Patient Satisfaction and Clinical Outcomes After Overnight Orthokeratology. Optom Vis Sci. 2009 Jul;86:875-882.
  3. Queiros A, Villa-Collar C, Gutiérrez, et al. Quality of Life of Myopic Subjects With Different Methods of Visual Correction Using the NEI RQL-42 Questionnaire. Eye & Contact Lens. 2012 Mar;38:116-121.
  4. Santodomingo-Rubido J, Villa-Collar C, Gilmartin B, Gutiérrez-Ortega R. Myopia Control With Orthokeratology Contact Lenses in Spain: A Comparison of Vision-Related Quality-of-Life Measures Between Orthokeratology Contact Lenses and Single-Vision Spectacles. Eye & Contact Lens. 2013 Mar;39:153-157.
  5. Berntsen DA, Mitchell GL, Barr JT. The Effect of Overnight Contact Lens Corneal Reshaping on Refractive Error-Specific Quality of Life. Optom Vis Sci. 2006 Jun;83:354-359.
  6. Santolaria E, Cerviño A, Queirós A, Brautaset R, González-Méijome JM. Subjective Satisfaction in Long-term Orthokeratology Patients. Eye and Cont Lens. 2013 Nov;39:388-393.
  7. Rose K, Harper R, Tromans C, et al. Quality Of Life In Myopia. Br J Ophth. 2000 Sep;84:1031-1034.
  8. McAlinden C, Lipson MJ. Orthokeratology and Contact Lens Quality of Life Questionnaire (OCL-QoL). Eye Contact Lens. 2018 Sep;4Hir4:279-285.

(p. 42) The Scleral Lens Vault – Reservoir Flux
By Gregory W. DeNaeyer, OD

  1. Skidmore KV, Walker MK, Marsack JD, Bergmanson JPG, Miller WL. A measure of tear inflow in habitual scleral lens wearers with and without midday fogging. Cont Lens Anterior Eye. 2019 Feb;42:36-42.
  2. Kauffman MJ, Gilmartin CA, Bennett ES, Bassi CJ. A comparison of the short-term settling of three scleral lens designs. Optom Vis Sci. 2014 Dec;91:1462-1466.
  3. Paugh JR, Chen E, Heinrich C, et al. Silicone Hydrogel and Rigid Gas-Permeable Scleral Lens Tear Exchange. Eye Contact Lens. 2018 Mar;44:97-101.
  4. Tse V, Tan B, Kim YH, Zhou Y, Lin MC. Tear Dynamics Under Scleral Lenses. Cont Lens Anterior Eye. 2019 Feb;42:43-48.
  5. Tan B, Zhou Y, Yuen T, Lin K, Michaud L, Lin MC. Effects of Scleral-lens Tear Clearance on Corneal Edema and Post-lens Tear Dynamics: A Pilot Study. Optom Vis Science. 2018 Jun;95:481-490.
  6. Pucker AD, Laurent JM. Scleral Contact Lens Complications. In Scleral Lenses: Advanced Fitting, Design, and Troubleshooting. A Supplement to Contact Lens Spectrum. 2018 Oct;32:24-27.
  7. Walker MK, Bergmanson JP, Miller WL, Marsack JD, Johnson LA. Complications and fitting challenges associated with scleral contact lenses: A review. Cont Lens Anterior Eye. 2016 Apr;39:88-96.
  8. Nichols JJ. December 2018 Quick Poll Results. Which of the following scleral lens ocular complications occurs most frequently in your practice. 2018 Dec 23. Available at https://www.clspectrum.com/newsletters/contact-lenses-today/december-23,-2018 . Accessed March 25, 2019.
  9. Carracedo G, Serramito-Blanco M, Martin-Gil A, Rodriguez-Pomar C, Pintor J. Post-lens tear turbidity and visual quality after scleral lens wear. Clin Exp Optom. 2017 Nov;100:577-582.
  10. Postnikoff CK, Pucker AD, Laurent J, Huisingh C, McGwin G, Nichols JJ. Identification of Leukocytes Associated With Midday Fogging in the Post-Lens Tear Film of Scleral Contact Lens Wearers. Invest Ophthalmol Vis Sci. 2019 Jan;60:226-233.
  11. Karres M, Fogt J, Menner A, Barr JT. Assessments of Mid-day Fogging with a Novel Scleral Lens Filling Solution. Poster presented at the Global Specialty Lens Symposium. Jan. 2019, Las Vegas. Available at https://etouches-appfiles.s3.amazonaws.com/html_file_uploads/0d2b9e495820876e98150f728118de6c_Karres2-compressed.pdf?response-content-disposition=inline%3Bfilename%3D%22Karres2-compressed.pdf%22&response-content-type=application%2Fpdf&AWSAccessKeyId=AKIAJC6CRYNXDRDHQCUQ&Expires=1553545097&Signature=Q%2FTGqY%2BcXPkK%2BIXUhM2iNDtPJiE%3D . Accessed March 25, 2019.

(p. 46) Reader and Industry Forum – Eradicating Pediatric Keratoconus
By Benjamin Azman, OD, & Irwin Azman, OD

  1. Panos GD, Kozeis N, Balidis M, Moschos MM, Hafezi F. Collagen Cross-Linking for Pediatric Keratoconus. Open Ophthalmol J. 2017 Jul;11:211-216
  2. Kankariya VP, Kymionis GD, Diakonis VF, Yoo SH. Managment of pediatric keratoconus - evolving role of corneal collagen cross-linking: an update. Indian J Ophthalmol. 2013 Aug;61:435-440.
  3. Chatzis N, Hafezi F. Progression of keratoconus and efficacy of pediatric corneal collagen cross-linking in children and adolescents. J Refract Surg. 2012 Nov;28:753-758.
  4. Cimberle M. Cornea specialist examines ways to assess keratoconus progression. Ocular Surgery News. 2017 May 25. Available at https://www.healio.com/ophthalmology/cornea-external-disease/news/print/ocular-surgery-news/%7Bae725908-8ffb-4ed1-8671-b0990dff9fc1%7D/cornea-specialist-examines-ways-to-assess-keratoconus-progression . Accessed April 8, 2019.
  5. Buzzonetti L, Valente P, Petrocelli G. Keratoconus in Children. In Alió, Jorge, ed. Keratoconus: Recent Advances in Diagnosis and Treatment. Springer International Publishing, 2017 Dec: 43-49.
  6. Eisenberg JS. First treatment for keratoconus itself. Optometry Times. 2012 June 1;2. Available at https://www.optometrytimes.com/modern-medicine-now/first-treatment-keratoconus-itself . Accessed April 8, 2019.
  7. Krader CG. Optometrists play important role in cornea collagen crosslinking. Optometry Times. 2011 May;3:38-39.

(p. 47) Reader and Industry Forum – Managing Ocular Viral Infection: Old Is New Again
By Agustin Gonzalez, OD

  1. Labetoulle M. Epidemiology of viral infections. Acta Ophthalmologica. 2009;87(suppl s244).
  2. Apt L, Isenberg S, Yoshimori R, Paez JH. Chemical preparation of the eye in ophthalmic surgery. III. Effect of povidone-iodine on the conjunctiva. Arch Ophthalmol. 1984 May;102:728-729.
  3. Sibbald RG, Leaper D, Queen D. Iodine Made Easy. Wounds International. 2011 May;2:1-6
  4. Clement C Capriotti JA, Kumar M, et al. Clinical and antiviral efficacy of an ophthalmic formulation of dexamethasone povidone-iodine in a rabbit model of adenoviral conjunctivitis. Invest Ophthalmol Vis Sci. 2011 Jan 21;52:339-344.
  5. Pelletier JS, Stewart K, Trattler W, et al. A combination povidone-iodine 0.4%/dexamethasone 0.1% ophthalmic suspension in the treatment of adenoviral conjunctivitis. Adv Ther. 2009 Aug;26:776-783.
  6. Pinto RD, Lira RP, Abe RY, et al. Dexamethasone/Povidone Eye Drops versus Artificial Tears for Treatment of Presumed Viral Conjunctivitis: A Randomized Clinical Trial. Curr Eye Res. 2015 Sep;40:870-877.
  7. Goldman D, Patel R. Pros and Cons of Topical Steroids for Viral Conjunctivitis. Cataract & Refractive Surgery Today. 2011 Sep:22-23.